This company listing is no longer active
CAJ Stock Overview
Provides diagnostic imaging modalities and related services to the healthcare market in Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
Capitol Health Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.39 |
| 52 Week High | AU$0.40 |
| 52 Week Low | AU$0.20 |
| Beta | 0.65 |
| 1 Month Change | -1.28% |
| 3 Month Change | 22.22% |
| 1 Year Change | 83.33% |
| 3 Year Change | 8.45% |
| 5 Year Change | 75.00% |
| Change since IPO | 45.28% |
Recent News & Updates
Recent updates
Calculating The Fair Value Of Capitol Health Limited (ASX:CAJ)
Jun 17
Capitol Health Limited's (ASX:CAJ) Popularity With Investors Is Clear
Jan 15Capitol Health (ASX:CAJ) Takes On Some Risk With Its Use Of Debt
Dec 15Is Capitol Health Limited (ASX:CAJ) Worth AU$0.3 Based On Its Intrinsic Value?
Oct 22Capitol Health (ASX:CAJ) Seems To Use Debt Rather Sparingly
May 28Should You Investigate Capitol Health Limited (ASX:CAJ) At AU$0.37?
Apr 16Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Mar 05Have Insiders Been Selling Capitol Health Limited (ASX:CAJ) Shares This Year?
Feb 14Did You Miss Capitol Health's (ASX:CAJ) 20% Share Price Gain?
Jan 19
Is Capitol Health Limited's (ASX:CAJ) Shareholder Ownership Skewed Towards Insiders?
Dec 22Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Dec 01Here's Why We Don't Think Capitol Health's (ASX:CAJ) Statutory Earnings Reflect Its Underlying Earnings Potential
Aug 17Is Now An Opportune Moment To Examine Capitol Health Limited (ASX:CAJ)?
Jul 25Is Capitol Health Limited's (ASX:CAJ) Latest Stock Performance A Reflection Of Its Financial Health?
Jul 04Shareholder Returns
| CAJ | AU Healthcare | AU Market | |
|---|---|---|---|
| 7D | 2.7% | 0.5% | -0.06% |
| 1Y | 83.3% | -5.5% | 9.0% |
Return vs Industry: CAJ exceeded the Australian Healthcare industry which returned 3.1% over the past year.
Return vs Market: CAJ exceeded the Australian Market which returned 14.8% over the past year.
Price Volatility
| CAJ volatility | |
|---|---|
| CAJ Average Weekly Movement | 5.3% |
| Healthcare Industry Average Movement | 5.4% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in AU Market | 16.6% |
| 10% least volatile stocks in AU Market | 3.0% |
Stable Share Price: CAJ has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: CAJ's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 1,000 | Justin Walter | www.capitolhealth.com.au |
Capitol Health Limited provides diagnostic imaging modalities and related services to the healthcare market in Australia. It offers a range of diagnostic imaging services, including general x-ray, magnetic resonance imaging, ultrasound, mammography, Doppler, orthopantomogram, echocardiography, computed tomography, CT angiography, cone beam CT, nuclear medicine, bone densitometry, and fluoroscopy. It operates various clinics in Victoria, Tasmania, Western Australia, and South Australia under the Capital Radiology brand, as well as under the Imaging Olympic Park, Radiology Tasmania, Fowler Simmons Radiology, Womens’ Imaging, Direct Radiology, and Future Medical Imaging Group brand names.
Capitol Health Limited Fundamentals Summary
| CAJ fundamental statistics | |
|---|---|
| Market cap | AU$410.44m |
| Earnings (TTM) | -AU$14.85m |
| Revenue (TTM) | AU$234.82m |
1.7x
P/S Ratio-27.6x
P/E RatioIs CAJ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CAJ income statement (TTM) | |
|---|---|
| Revenue | AU$234.82m |
| Cost of Revenue | AU$178.96m |
| Gross Profit | AU$55.86m |
| Other Expenses | AU$70.71m |
| Earnings | -AU$14.85m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.014 |
| Gross Margin | 23.79% |
| Net Profit Margin | -6.33% |
| Debt/Equity Ratio | 74.8% |
How did CAJ perform over the long term?
See historical performance and comparisonDividends
2.1%
Current Dividend Yield-64%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/11 13:42 |
| End of Day Share Price | 2024/12/11 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Capitol Health Limited is covered by 9 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Russell Wright | Barclay Pearce Capital Pty Limited |
| Andrew Hodge | Credit Suisse |
| Daniel Downes | Goldman Sachs |